Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating and/or reducing the likelihood of heart failure by administering anti-activin receptor type II (anti-ActRII) antibody

Methods for treating and/or reducing the likelihood of heart failure by administering anti-activin receptor type II (anti-ActRII) antibody

US Patent 10982000 · Granted Apr 20, 2021

Estimated economic value: $58,054,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gas supply apparatus for substrate processing apparatus2025
Rapamycin derivatives2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025
Compositions and methods for promoting patency of vascular grafts2025
Rapamycin derivatives2024
Method of treating structural and/or functional cardiac abnormalities by adminis2023
Method of treating structural and/or functional cardiac abnormalities by adminis2023
Method of treating structural and/or functional cardiac abnormalities by adminis2023
Treatment of cancer using a CD123 chimeric antigen receptor2023
Regulatable chimeric antigen receptor2023
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chim2022
Anti-BCMA chimeric antigen receptor2021